PL4262773T3 - Zawierająca kwas mlekowy kompozycja do stosowania w leczeniu przepukliny krążka międzykręgowego - Google Patents
Zawierająca kwas mlekowy kompozycja do stosowania w leczeniu przepukliny krążka międzykręgowegoInfo
- Publication number
- PL4262773T3 PL4262773T3 PL21844208.5T PL21844208T PL4262773T3 PL 4262773 T3 PL4262773 T3 PL 4262773T3 PL 21844208 T PL21844208 T PL 21844208T PL 4262773 T3 PL4262773 T3 PL 4262773T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- composition
- lactic acid
- intervertebral disc
- disc herniation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE2051481 | 2020-12-17 | ||
| PCT/EP2021/086409 WO2022129476A1 (en) | 2020-12-17 | 2021-12-17 | A composition for use in the treatment of intervertebral disc herniation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4262773T3 true PL4262773T3 (pl) | 2025-06-09 |
Family
ID=79686812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21844208.5T PL4262773T3 (pl) | 2020-12-17 | 2021-12-17 | Zawierająca kwas mlekowy kompozycja do stosowania w leczeniu przepukliny krążka międzykręgowego |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20240415790A1 (pl) |
| EP (1) | EP4262773B1 (pl) |
| JP (1) | JP7899180B2 (pl) |
| KR (1) | KR20230121821A (pl) |
| CN (1) | CN116615190A (pl) |
| AU (1) | AU2021403841A1 (pl) |
| CA (1) | CA3202177A1 (pl) |
| DK (1) | DK4262773T3 (pl) |
| ES (1) | ES3030835T3 (pl) |
| FI (1) | FI4262773T3 (pl) |
| HR (1) | HRP20250560T1 (pl) |
| HU (1) | HUE071352T2 (pl) |
| IL (1) | IL303520A (pl) |
| LT (1) | LT4262773T (pl) |
| MX (1) | MX2023007313A (pl) |
| PL (1) | PL4262773T3 (pl) |
| PT (1) | PT4262773T (pl) |
| RS (1) | RS66773B1 (pl) |
| SI (1) | SI4262773T1 (pl) |
| WO (1) | WO2022129476A1 (pl) |
| ZA (1) | ZA202306681B (pl) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800550A (en) | 1996-03-13 | 1998-09-01 | Sertich; Mario M. | Interbody fusion cage |
| CA2358387C (en) | 1998-12-31 | 2007-11-13 | Jeffrey E. Yeung | Tissue fastening devices and delivery means |
| WO2001095818A1 (en) | 2000-06-12 | 2001-12-20 | Yeung Jeffrey E | Intervertebral disc repair |
| ATE336953T1 (de) | 2001-02-13 | 2006-09-15 | Jeffrey E Yeung | Kompressionsvorrichtung und trokar zum reparieren einer zwischenwirbelprothese |
| US8690857B2 (en) | 2010-07-23 | 2014-04-08 | Aleeva Medical Inc. | Alleviate back pain with lactic acid inhibitors |
| ITPI20110143A1 (it) | 2011-12-20 | 2013-06-21 | Univ Pisa | Agenti terapeutici in grado di ridurre la produzione cellulare di acido lattico e composizioni farmaceutiche che comprendono tali composti |
| RS59285B1 (sr) * | 2014-03-20 | 2019-10-31 | Stayble Therapeutics Ab | Kompozicija za upotrebu u lečenju bola povezanog sa intervertebralnim diskom |
| SE1550338A1 (en) * | 2015-03-20 | 2016-09-21 | Stayble Therapeutics Ab | A composition for use in the treatment of intervertebral misalignment |
| EP3349852B1 (en) * | 2015-09-14 | 2026-03-04 | Stayble Therapeutics Ab | A composition for use in the treatment of intervertebral disc-related pain |
-
2021
- 2021-12-17 PL PL21844208.5T patent/PL4262773T3/pl unknown
- 2021-12-17 HR HRP20250560TT patent/HRP20250560T1/hr unknown
- 2021-12-17 MX MX2023007313A patent/MX2023007313A/es unknown
- 2021-12-17 IL IL303520A patent/IL303520A/en unknown
- 2021-12-17 ES ES21844208T patent/ES3030835T3/es active Active
- 2021-12-17 SI SI202130309T patent/SI4262773T1/sl unknown
- 2021-12-17 PT PT218442085T patent/PT4262773T/pt unknown
- 2021-12-17 KR KR1020237023777A patent/KR20230121821A/ko active Pending
- 2021-12-17 FI FIEP21844208.5T patent/FI4262773T3/fi active
- 2021-12-17 JP JP2023536818A patent/JP7899180B2/ja active Active
- 2021-12-17 US US18/267,648 patent/US20240415790A1/en active Pending
- 2021-12-17 LT LTEPPCT/EP2021/086409T patent/LT4262773T/lt unknown
- 2021-12-17 EP EP21844208.5A patent/EP4262773B1/en active Active
- 2021-12-17 DK DK21844208.5T patent/DK4262773T3/da active
- 2021-12-17 CA CA3202177A patent/CA3202177A1/en active Pending
- 2021-12-17 HU HUE21844208A patent/HUE071352T2/hu unknown
- 2021-12-17 CN CN202180083908.1A patent/CN116615190A/zh active Pending
- 2021-12-17 WO PCT/EP2021/086409 patent/WO2022129476A1/en not_active Ceased
- 2021-12-17 RS RS20250442A patent/RS66773B1/sr unknown
- 2021-12-17 AU AU2021403841A patent/AU2021403841A1/en active Pending
-
2023
- 2023-06-29 ZA ZA2023/06681A patent/ZA202306681B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230121821A (ko) | 2023-08-21 |
| AU2021403841A9 (en) | 2024-02-08 |
| ZA202306681B (en) | 2024-10-30 |
| EP4262773B1 (en) | 2025-03-26 |
| ES3030835T3 (en) | 2025-07-02 |
| US20240415790A1 (en) | 2024-12-19 |
| SI4262773T1 (sl) | 2025-06-30 |
| CA3202177A1 (en) | 2022-06-23 |
| WO2022129476A1 (en) | 2022-06-23 |
| CN116615190A (zh) | 2023-08-18 |
| FI4262773T3 (fi) | 2025-04-30 |
| MX2023007313A (es) | 2023-07-04 |
| IL303520A (en) | 2023-08-01 |
| DK4262773T3 (da) | 2025-04-28 |
| JP2024500738A (ja) | 2024-01-10 |
| HRP20250560T1 (hr) | 2025-07-04 |
| AU2021403841A1 (en) | 2023-06-29 |
| JP7899180B2 (ja) | 2026-08-03 |
| RS66773B1 (sr) | 2025-05-30 |
| PT4262773T (pt) | 2025-05-16 |
| EP4262773A1 (en) | 2023-10-25 |
| HUE071352T2 (hu) | 2025-08-28 |
| LT4262773T (lt) | 2025-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3979982T3 (pl) | Kompozycja zawierająca bakteryjny szczep lactobacillus paracasei i kwas hialuronowy oraz jej zastosowanie do leczenia skóry | |
| GB2590794B (en) | Plant Extract or Synthetic CBD-C6 for use in therapy | |
| EP2427167A4 (en) | METHOD AND COMPOSITION FOR RECOVERING AGED-INFUSED TISSUE LOSS IN THE FACE OR PARTICULAR BODY RANGE | |
| PH12012502464A1 (en) | Therapeutic oral composition | |
| WO2016086210A8 (en) | Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease | |
| NZ715667A (en) | Oral compositions | |
| PT4148050T (pt) | Novo inibidor da secreção ácida e sua utilização | |
| WO2014027965A8 (en) | Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells | |
| IL292726A (en) | Intraneural bioactive dental implant | |
| MY185054A (en) | Rolled collagen carrier | |
| HUE071972T2 (hu) | Vegyületek és készítmények bõrrendellenességek kezelésében történõ alkalmazásra | |
| ZA202205007B (en) | Personal care compositions for treating odor causing bacteria and methods for the same | |
| SI4262773T1 (sl) | Sestava z mlečno kislino za uporabo pri zdravljenju zdrsa medvretenčne ploščice | |
| HUE067967T2 (hu) | Szarakatinib idiopátiás tüdõfibrózis kezelésében történõ alkalmazásra | |
| EP2502989A4 (en) | IMPLANT COMPOSITION FOR THE REGENERATION OF NEURAL TISSUE, PREPARATION METHOD AND USES THEREOF | |
| AU2015233396B2 (en) | A composition for use in the treatment of intervertebral disc-related pain | |
| GB201918414D0 (en) | Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency | |
| GB201918410D0 (en) | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | |
| SG11202006957WA (en) | Liquid composition for oral use containing collagen peptide, and method for alleviating the acidity of liquid composition for oral use | |
| WO2021111426A3 (en) | Histatin-1 formulation for the treatment, repair or regeneration of bone tissue in a subject | |
| PL3911347T3 (pl) | Kompozycja do stosowania w leczeniu nietrzymania moczu u kobiet | |
| GB202002299D0 (en) | Agents for use in the treatment of tissue damage | |
| CA3261529A1 (en) | Hydrogel composition intended for use in the treatment of joint disorders | |
| IL288307A (en) | Preparations for use in the treatment of insulin deficiency conditions | |
| EP3031441A4 (en) | Curable calcium phosphate composition for in vivo hard tissue repair, bone repair material, and various dental materials |